Literature DB >> 15754452

Efavirenz reclassified as FDA pregnancy category D.

Lynne M Mofenson1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15754452

Source DB:  PubMed          Journal:  AIDS Clin Care        ISSN： 1043-1543


× No keyword cloud information.
  5 in total

Review 1.  HIV and pregnancy.

Authors:  Glenda E Gray; James A McIntyre
Journal:  BMJ       Date:  2007-05-05

2.  First trimester exposure to antiretroviral therapy and risk of birth defects.

Authors:  Kelesitse Phiri; Sonia Hernandez-Diaz; Kate B Dugan; Paige L Williams; Judith A Dudley; Astride Jules; S Todd Callahan; George R Seage; William O Cooper
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

3.  Efavirenz use during pregnancy and for women of child-bearing potential.

Authors:  Matthew F Chersich; Michael F Urban; Francois W D Venter; Tina Wessels; Amanda Krause; Glenda E Gray; Stanley Luchters; Dennis L Viljoen
Journal:  AIDS Res Ther       Date:  2006-04-07       Impact factor: 2.250

4.  German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.

Authors:  Bernd Buchholz; Matthias Beichert; Ulrich Marcus; Thomas Grubert; Andrea Gingelmaier; Annette Haberl; Brigitte Schmied
Journal:  Eur J Med Res       Date:  2009-11-03       Impact factor: 2.175

5.  Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?

Authors:  Lee Fairlie; Catriona Waitt; Shahin Lockman; Michelle Moorhouse; Elaine J Abrams; Polly Clayden; Marta Boffito; Saye Khoo; Helen Rees; Amandine Cournil; Willem Francois Venter; Celicia Serenata; Matthew Chersich
Journal:  J Int AIDS Soc       Date:  2019-09       Impact factor: 5.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.